Tag: Federal Circuit
Federal Circuit Court: Authority on Pharmaceutical Patent Cases
Barbara Lalicki
July 28, 2026
Medications
9 Comments
Explore the Federal Circuit's exclusive authority over pharmaceutical patent cases, covering key precedents like Mylan, Hatch-Waxman disputes, and the impact on generic drug timelines.
read more
